The Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR) Administrative Unit aims to effectively generate and administer the policies, procedures, communications, and funds associated with CEGIR. The CEGIR Administrative Unit will be integral in coordinating decision-making and implementation to achieve the objectives of CEGIR. The CEGIR Administrative Unit will include the CEGIR Director (Principal Investigator), Administrative Director, and the CEGIR Internal CEGIR Steering Committee. The Internal CEGIR Steering Committee has strong patient advocacy group [PAG;e.g. American Partnership for Eosinophilic Disorders (APFED) and Campaign Urging Research for Eosinophilic Diseases (CURED)] and professional medical research group representation [e.g. International Eosinophil Society (lES) and The International Gastrointestinal Eosinophil Researchers (TIGER)]. Specific activities ofthe CEGIR Administrative Unit include but are not limited to the following: 1) generate and administer policies;2) administer and monitor funds;3) ensure proper research conduct by all sites, including patient enrollment and retention;4) review reports from each CEGIR program/component;5) communicate and report to the National Institutes of Health (NIH) and other regulatory bodies;6) disseminate findings, including publications;7) disseminate web-based information as per NIH guidelines and directives;8) foster integration and partnership with PAGs;9) report to the External Advisory Board (EAB) and review their recommendations;and 10) conduct regular teleconferences, webinars, and meetings.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
1U54AI117804-01
Application #
8894260
Study Section
Special Emphasis Panel (ZTR1-CI-8 (01))
Project Start
Project End
Budget Start
2014-08-15
Budget End
2015-07-31
Support Year
1
Fiscal Year
2014
Total Cost
$228,100
Indirect Cost
$50,212
Name
Cincinnati Children's Hospital Medical Center
Department
Type
DUNS #
071284913
City
Cincinnati
State
OH
Country
United States
Zip Code
45229
Naramore, Sara; Gupta, Sandeep K (2018) Nonesophageal Eosinophilic Gastrointestinal Disorders: Clinical Care and Future Directions. J Pediatr Gastroenterol Nutr 67:318-321
Steinbach, Erin C; Hernandez, Michelle; Dellon, Evan S (2018) Eosinophilic Esophagitis and the Eosinophilic Gastrointestinal Diseases: Approach to Diagnosis and Management. J Allergy Clin Immunol Pract 6:1483-1495
Spergel, Jonathan; Aceves, Seema S (2018) Allergic components of eosinophilic esophagitis. J Allergy Clin Immunol 142:1-8
Hill, David A; Spergel, Jonathan M (2018) Is eosinophilic esophagitis a member of the atopic march? Ann Allergy Asthma Immunol 120:113-114
Spergel, Jonathan M; Dellon, Evan S; Liacouras, Chris A et al. (2018) Summary of the updated international consensus diagnostic criteria for eosinophilic esophagitis: AGREE conference. Ann Allergy Asthma Immunol 121:281-284
Wechsler, Joshua B; Hirano, Ikuo (2018) Biological therapies for eosinophilic gastrointestinal diseases. J Allergy Clin Immunol 142:24-31.e2
O'Shea, Kelly M; Aceves, Seema S; Dellon, Evan S et al. (2018) Pathophysiology of Eosinophilic Esophagitis. Gastroenterology 154:333-345
Shoda, Tetsuo; Wen, Ting; Aceves, Seema S et al. (2018) Eosinophilic oesophagitis endotype classification by molecular, clinical, and histopathological analyses: a cross-sectional study. Lancet Gastroenterol Hepatol 3:477-488
Wang, Ryan; Hirano, Ikuo; Doerfler, Bethany et al. (2018) Assessing Adherence and Barriers to Long-Term Elimination Diet Therapy in Adults with Eosinophilic Esophagitis. Dig Dis Sci 63:1756-1762
Hill, David A; Spergel, Jonathan M (2018) The atopic march: Critical evidence and clinical relevance. Ann Allergy Asthma Immunol 120:131-137

Showing the most recent 10 out of 103 publications